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SUMMARY.-Male and female Swiss strain mice were put on a 0.03% thioace-
tamide diet at the age of 2 months. Control mice were kept on a stock diet.
Control and treated mice were killed at the ages of 6, 9, 13 and 17 months.
Progressive morphological, histological and biochemical alterations in the
liver and tumour tissue of the treated mice were studied. In the 17-month-old
group, 12 out of 13 treated mice developed hepatomas.
THIOACETAMIDE, which was originally used for prevention of orange decay,
was first reported to be a hepatotoxic agent in albino rats by Fitzhugh and
Nielson (1948). In further studies Gupta (1956) reported that hepatocaroinomas
were induced by prolonged feeding of thioacetamide to Wistar strain rats. A
great deal of work has been done since then on the effects of thioacetamide on
cations (Rees, 1964), as well as on nuclei and nucleoli (Kleinfold and Koulish,
1957). However, its carcinogenic effect on mice has not been reported so far.
A series of experiments was therefore undertaken to explore the susceptibility of
Swiss strain mice to the carcinogenic effect of thioacetamide. The present paper
reports salient observations on progressive morphological, histological and
biochemical alterations that take place in the liver tissue of thioacetamide-fed
mice.
MATERIAL AND METHODS
Swiss strain mice, from the Animal colony of the Cancer Research Institute,
Bombay, were used for experimental purposes. A total number of 89 mice of
both sexes were used in this preliminary study. Experimental mice were put
on stock diet containing 003%0 thioacetamide at the age of 2 months. Control
mice were kept on stock diet alone (Ranadive, 1957). Food and water were
available ad libitum. Mice were killed at the ages of 6, 9, 13 and 17 months in
groups. The following schedule was used for killing the control and treated mice.
Age at killing
in months Control TreatedI
6 6d + 6? 6 + 6 ?
9 6d + 4y 4d + 6?
13 4c + 4y 6S + 6Y
17 6d + 6Y 6d + 7Y
Body weight was recorded before killing. Mice were killed by decapitation and
the entire liver was carefully dissected out along with tumour, whenever present,
and weighed on a torsion balance. Pieces of the median lobe and of the liverTUMORIGENICITY OF THIOACETAMIDE
tumour were fixed in 10% neutral formalin for histopathological study and the
remaining portions of liver and tumour were used for biochemical experiments.
Biochemical studies were carried out on the following parameters, namely ribo-
nucleic acid (RNA), deoxyribonucleic acid (DNA) and protein. RNA was esti-
mated by the method of Ogur and Rosen (1950). DNA was estimated by the
method of Ceriotti (1952). Both the nucleic acids were measured in ,tg. per pg.
of protein and per mg. of tissue. Protein was estimated by Folin phenol method
and expressed in terms of ,ug. of protein per mg. tissue (Lowry et al., 1951). For
histopathological study 6 It thick sections of paraffin embedded tissues were
stained with haematoxylin and eosin. A few sections were also stained by
Mallory's trichrome method.
RESULTS
Gross Observations
Control groups
The livers of mice of both sexes fed with stock diet appeared normal in colour
and size. Liver weights and liver-weight/body-weight ratios were more or less
constant (Table I). In the oldest group (17 months) the liver colour changed to a
darker shade and there was a slight increase in the liver weight, yet the liver-
weight/body-weight ratio of this group was comparable with that of the other
control groups.
TABLE 1.-Liver-Weight, Body-Weight Ratio in Thioacetamide-Treated Swiss Mice
Liver weight
Age _
(months) Liver weight Body weight
6 . Control 10 1.1 . 0-04 0-04
Treated1-2 1*3 0*044 0*05
9 . Control I1 1.1 . 0.04 0-05
Treated I -3 1-3 . 0-053 0 05
13 Control I3 1.2 . 0.04 0-05
Treated 18 1- 6 . 0 06 0*06
17 Control 14 1-3 . 0*05 0 05
Treated3-0 2-4 0-12 0.1
Treated groups
Six-month group.-In both male and female mice, the liver showed a normal
appearance. The colour was darker than that of the corresponding control
group. Liver weights of the control and treated groups were comparable.
Nine-month group.-In all these animals the outer surface as well as the cut
surface was finely granular. Besides, in four instances, two in male and two in
female, a few small rounded nodules were seen. Liver colour in both the sexes
was darker than in control groups. Liver weight increased slightly but the liver-
weight/body-weight ratio remained comparable in control and treated groups.
Thirteen-month group.-Granularity was marked in the liver tissue of these
animals. In three instances, in females, a few nodules were seen. Change in
colour and weight of the liver was more prominent. The size of the liver lobes
was also larger than that of the control groups. The liver weight and Jiver-
weight/body-weight ratio increased in both the sexes.
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Seventeen-month group.-In all these animals, except one, greyish-white
nodular areas were seen (Fig. 1). These varied from 0-5 cm. to 2-0 cm. Maximum
tumour weight observed was 9-0 g. and the mean liver-weight/body-weight ratio
in this group was 0-12, which is significantly higher than that in the corresponding
control group. A careful search for secondary lesions in other organs such as
lung, lymph nodes, etc., did not reveal any evidence of metastasis.
Microscopical Observations
The histological structure of sections of liver from control animals was essen-
tially normal except in two instances. These revealed fatty changes in hepatic
cells.
Histological examination ofthe sections from the liver in 6 months old treated
animals showed a mild generalised hypertrophy ofhepatic cells. There was slight
irregularity in the hepatic architecture. In the next group, that is in 9-month-old
treated mice, changes ofgeneralised hypertrophy ofhepatic cells were more clearly
seen. Bile duct proliferation was also present. In four instances, two in either
sex, microscopical examination ofthe nodules showed evidence ofregeneration.
Microscopical examination of the sections of liver from the 13-month-old
treated mice showed cirrhosis (Fig. 2). In one of these, cholangiofibrosis (Fig. 3)
was seen and in two regenerating nodules were present (Fig. 4). In the 17-month-
old group all the treated males and six out of seven treated females developed
hepatomas. These hepatomas were composed of irregular cords of cells resem-
bling hepatic cells. The cytoplasm was granular and cell margins were not
distinct. Nuclei were large and vesicular, and nucleoli were present. Mitotic
figures were seen in fair number (Fig. 5, 6). Although metastatic lesions were not
seen, the histological structure of these tumours was consistent with that of
carcinoma. A few of these tumours were transplanted subcutaneously in the
same strain mice. Palpable tumours in the transplanted mice were observed
after 4-6 months.
Biochemical Studies
Fig. 7 shows the levels of RNA and DNA measured per ,ug. of protein in the
liver tissue of different age groups as well as in the tumour tissue ofthe male and
female mice treated with thioacetamide. It may be observed that both RNA
and DNA levels in the treated liver tissue are comparable with those in the corres-
ponding control groups. DNA and RNA levels in the tumour tissue, in males,
however, are significantly higher than those in the corresponding control liver
tissue.
Table II shows the levels of RNA and DNA and protein measured per mg.
tissue in different age-groups of thioacetamide-treated mice. In this case, too,
EXPLANATION OF PLATES
FIG. 1.-Nodules ofhepatoma in a mouse of the 17-month-old treated group.
FIG. 2.-Section of liver showing cirrhosis (13-month-old group). H. and E. x 120.
FIG. 3.-Section of liver showing cholangiofibrosis (13-month-old group). H. and E. x 195.
FIG. 4.-Section from regenerating nodule from liver (13-month-old treated group). H. and
E. x 195.
FIG. 5.-Hepatoma in an animal ofthe 17-month-old group. H. and E. x 195.
FIG. 6.-High power view to the same field seen in Fig. 5. H. and E. x 390.
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FIG. 7.-RNA and DNA levels in liver tissuie and thioacetamide-treated Swiss mice.
* 0- RNA level in control group.
x- - - x RNA level in treated group.
O 0 DNA level in control group.
x x DNA level in treated group.
it is apparent that both the nucleic acid levels in liver tissue of treated groups are
comparable with those in the corresponding control groups. The turnour tissue
has significantly higher values of DNA and RNA content than those of the corres-
ponding control liver tissue. Protein values per mg. tissue, however, do not vary
in all the different groups under study.
DISCUSSION
The toxic effects of thioacetamide administration on different tissues has been
reported by various workers (Ambrose, 1949; Hruban et al., 1966; Rather, 1951;
Hagemann, 1959; Miyazaki, Wada and Takayanagi, 1956). It has also been
shown that thioacetamide feeding induces hepatocarcinoma in Wistar strain
rats (Gupta, 1956).
Observations in the present series of experiments clearly indicate that Swiss
strain mice are susceptible to the carcinogenic effect of thioacetamide. Further,
it is apparent that both sexes are susceptible to thioacetamide treatment. Toxic
effects of thioacetamide on mice have been reported previously (Sapre, Gothoskar
and Bhide, 1969), but the tumorigenic effect of thioacetamide on liver tissue in
this particular species has not been reported so far.
In the present experiments, the significantly high incidence of hepatomas
indicates that mouse liver is very susceptible to the tumorigenic effect of thioace-
tamide.
From the biochemical studies it is evident that nucleic acid levels in liver tissue
of the treated mice remain comparable with those in the corresponding control
group, but in the hepatomas the contents ofboth the nucleic acids are significantly
higher than in the control group. Increased nucleic acid levels in tumour tissue
have been reported previously, (Schmidt, 1959). Unlike nucleic acids, the content
of protein in the tumour tissue is comparable with that in the liver tissue of the
corresponding control groups. It is conceivable that the protein content of the
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tumour tissue increases along with the increase in tumour weight and hence the
increase in protein content of the tumour is not apparent as such.
To summarize it may be stated that thioacetamide is a potent hepatocarcinogen
in Swiss strain mice and it does not show particular preference to either sex.
The authors acknowledge the technical help rendered by Mr. P. V. Parab.
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